Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions
β Scribed by Robert A. Wilcox; Andrew Churchyard; Henrik H. Dahl; Wendy M. Hutchison; Denise M. Kirby; Dominic Thyagarajan
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 157 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We report a patient with an autosomal dominant chronic progressive external ophthalmoplegia phenotype associated with multiple mtDNA deletions in muscle from a family in which linkage analysis excluded mutations in DNA polymerase Ξ³ (POLG), adenine nucleotide translocase (ANTβ1) or C10orf2 (Twinkle). She presented with prominent Parkinsonism characterized by prolonged benefit from levodopa (Lβdopa) and the later development of Lβdopa induced dyskinesias and motor fluctuations. Thus Lβdopa responsiveness, Lβdopa induced dyskinesias and motor fluctuations may also occur in atypical Parkinsonism of mitochondrial disease, just as they may in multiple system atrophy. Β© 2007 Movement Disorder Society
π SIMILAR VOLUMES
Inclusion body myositis (IBM) is a sporadic progressive myopathy, which is morphologically characterized by inflammatory cell infiltrates and rimmed vacuoles in muscle fibers. Mitochondrial changes are regularly present with ragged-red fibers showing deficiency of cytochrome c oxidase. In these musc
The accumulation of multiple mitochondrial DNA (mtDNA) deletions in stable tissues is a distinctive feature of several autosomal disorders, characterized by Progressive External Ophthalmoplegia (PEO), ptosis, and proximal myopathy. At least three nuclear genes are responsible for these disorders: AN